Nxstage Medical, Inc. (NXTM) Tops Q2 EPS by 1c; Guides Wider Q3 Loss; Gets EU Approval for New Bolus Use

Go back to Nxstage Medical, Inc. (NXTM) Tops Q2 EPS by 1c; Guides Wider Q3 Loss; Gets EU Approval for New Bolus Use